From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution
Publication date: Available online 20 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Tran Thị Van Anh, Alilou Mostafa, Zhigang Rao, Simona Pace, Stefan Schwaiger, Christian Kretzer, Veronika Temml, Carsten Giesel, Paul M. Jordan, Rossella Bilancia, Christina Weinigel, Silke Rummler, Birgit Waltenberger, Tran Hung, Antonietta Rossi, Hermann Stuppner, Oliver Werz, Andreas Koeberle (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 20, 2021 Category: Cancer & Oncology Source Type: research
Cancer-specific calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced anti-metastasis combinational chemotherapy
Publication date: Available online 18 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Dan Li, Yingli Wang, Chang Li, Qiu Wang, Bingjun Sun, Haotian Zhang, Zhonggui He, Jin Sun (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 18, 2021 Category: Cancer & Oncology Source Type: research
Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis
Publication date: Available online 18 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Heng Li, Yao Zhang, Moting Liu, Chen Fan, Chunlan Feng, Qiukai Lu, Caigui Xiang, Huimin Lu, Xiaoqian Yang, Bing Wu, Duowu Zou, Wei Tang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 18, 2021 Category: Cancer & Oncology Source Type: research
Functional identification of the terpene synthase family involved in diterpenoid alkaloids biosynthesis in Aconitum carmichaelii
Publication date: Available online 18 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Liuying Mao, Baolong Jin, Lingli Chen, Mei Tian, Rui Ma, Biwei Yin, Haiyan Zhang, Juan Guo, Jinfu Tang, Tong Chen, Changjiangsheng Lai, Guanghong Cui, Luqi Huang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 18, 2021 Category: Cancer & Oncology Source Type: research
Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
Publication date: Available online 22 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Jiashu Xie, Zhengqiang Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 16, 2021 Category: Cancer & Oncology Source Type: research
Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis
Publication date: Available online 13 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Wenqi Yu, Ruyi Lin, Xueqin He, Xiaotong Yang, Huilin Zhang, Chuan Hu, Rui Liu, Yuan Huang, Yi Qin, Huile Gao (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 13, 2021 Category: Cancer & Oncology Source Type: research
Integrins as attractive targets for cancer therapeutics
Publication date: Available online 10 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Meng Li, Ying Wang, Mengwei Li, Xuezhen Wu, Sarra Setrerrahmane, Hanmei Xu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 11, 2021 Category: Cancer & Oncology Source Type: research
An update on oral drug delivery via intestinal lymphatic transport
Publication date: Available online 9 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zichen Zhang, Yi Lu, Jianping Qi, Wei Wu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 10, 2021 Category: Cancer & Oncology Source Type: research
Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy
Publication date: Available online 5 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ziyan Zhang, Qiaojuan Liu, Jizhou Tan, Xiaoxia Zhan, Ting Liu, Yuting Wang, Gen Lu, Minhao Wu, Yuanqing Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 6, 2021 Category: Cancer & Oncology Source Type: research
Antibody‒drug conjugates: Recent advances in linker chemistry
Publication date: Available online 6 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zheng Su, Dian Xiao, Fei Xie, Lianqi Liu, Yanming Wang, Shiyong Fan, Xinbo Zhou, Song Li (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 6, 2021 Category: Cancer & Oncology Source Type: research
3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing
Publication date: Available online 6 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Lina Xu, Lianhong Yin, Yan Qi, Xuemei Tan, Meng Gao, Jinyong Peng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 6, 2021 Category: Cancer & Oncology Source Type: research
HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation
Publication date: Available online 2 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Wei Tian, Jiatong Li, Zhuo Wang, Tong Zhang, Ying Han, Yanyan Liu, Wenfeng Chu, Yu Liu, Baofeng Yang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 3, 2021 Category: Cancer & Oncology Source Type: research
Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis
Publication date: Available online 2 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xu Cheng, Dapeng Li, Jiaxi Xu, Bing Wei, Qin Fang, Longshun Yang, Yanbing Xue, Xin Wang, Rupei Tang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 3, 2021 Category: Cancer & Oncology Source Type: research
Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping
Publication date: Available online 1 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhen Chen, Wakana Mori, Jian Rong, Michael A. Schafroth, Tuo Shao, Richard S. Van, Daisuke Ogasawara, Tomoteru Yamasaki, Atsuto Hiraishi, Akiko Hatori, Jiahui Chen, Yiding Zhang, Kuan Hu, Masayuki Fujinaga, Jiyun Sun, Qingzhen Yu, Thomas L. Collier, Yihan Shao, Benjamin F. Cravatt, Lee Josephson (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 2, 2021 Category: Cancer & Oncology Source Type: research
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
Publication date: Available online 1 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiaojia Liu, Mingxiao Yin, Jingwen Dong, Genxiang Mao, Wenjian Min, Zean Kuang, Peng Yang, Lu Liu, Na Zhang, Hongbin Deng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - April 1, 2021 Category: Cancer & Oncology Source Type: research
